Filing Details

Accession Number:
0000950170-24-121444
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-05 16:05:04
Reporting Period:
2024-10-29
Accepted Time:
2024-11-05 16:05:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883107 Nanophase Technologies Corp NANX Perfumes, Cosmetics & Other Toilet Preparations (2844) 363687863
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1173970 Janet R Whitmore 1319 Marquette Drive
Romeoville IL 60446
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-10-29 2,000 $0.90 2,005,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 2,000 $1.05 2,007,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 2,000 $1.18 2,009,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 2,000 $0.84 2,011,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 2,000 $1.10 2,013,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 2,000 $0.99 2,015,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 10,000 $0.68 2,025,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 10,000 $0.82 2,035,809 No 4 P Direct
Common Stock Acquisiton 2024-10-29 6,667 $0.45 2,042,476 No 4 P Direct
Common Stock Acquisiton 2024-10-29 6,666 $1.17 2,049,142 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 2,000 $0.90 2,000 $0.90
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 2,000 $1.05 2,000 $1.05
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 2,000 $1.18 2,000 $1.18
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 2,000 $0.84 2,000 $0.84
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 2,000 $1.10 2,000 $1.10
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 2,000 $0.99 2,000 $0.99
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 10,000 $0.68 10,000 $0.68
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 10,000 $0.82 10,000 $0.82
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 6,667 $0.45 6,667 $0.45
Common Stock Common Stock (Right to Buy) Disposition 2024-10-29 20,000 $1.17 6,667 $1.17
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-11-17 2026-11-17 No 4 M Direct
0 2017-11-17 2026-11-17 No 4 M Direct
0 2017-11-17 2026-11-17 No 4 M Direct
0 2017-11-17 2026-11-17 No 4 M Direct
0 2017-11-17 2026-11-17 No 4 M Direct
0 2017-11-17 2026-11-17 No 4 M Direct
0 2018-02-21 2027-02-21 No 4 M Direct
0 2019-05-23 2028-05-23 No 4 M Direct
0 2021-06-18 2027-06-18 No 4 M Direct
13,334 2023-12-20 2029-12-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,003,809 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Deferred Common Stock $0.00 20,030 20,030 Direct
Common Stock Common Stock (right to purchase) $1.85 2016-11-17 2026-11-17 2,000 2,000 Direct
Common Stock Common Stock (right to purchase) $4.17 2022-12-28 2028-12-28 20,000 20,000 Direct
Common Stock Common Stock (right to purchase) $0.61 2024-12-27 2030-12-27 12,600 12,600 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
20,030 20,030 Direct
2026-11-17 2,000 2,000 Direct
2028-12-28 20,000 20,000 Direct
2030-12-27 12,600 12,600 Direct
Footnotes
  1. Each share of deferred common stock represents the right to receive one share of common stock.
  2. The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
  3. Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan.
  4. The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.
  5. Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.